Market Cap 106.50M
Revenue (ttm) 7.95M
Net Income (ttm) -21.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -267.04%
Debt to Equity Ratio 0.00
Volume 186,407
Avg Vol 220,866
Day's Range N/A - N/A
Shares Out 23.46M
Stochastic %K 1%
Beta 0.51
Analysts Strong Sell
Price Target $15.19

Company Profile

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. The company develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 587 8170
Address:
5850 San Felipe St., Suite 500, Houston, United States
Layne_Thomas_Staley
Layne_Thomas_Staley Jul. 21 at 3:40 PM
$IBB $XBI $GANX $COYA Yes X1000
0 · Reply
Layne_Thomas_Staley
Layne_Thomas_Staley Jul. 21 at 3:33 PM
$XBI $GANX $COYA XBI is key until news. A rising XBI will provide an impetus for larger players to assume greater risk and accumulate at current prices.
0 · Reply
zampy
zampy Jul. 21 at 10:52 AM
$COYA at $6 RSI was 72 now at $4.X. 40 ( this is the price Dr Reddy's paid as well as David Eihorn whete we raised 22m clean no warrants) we are at a very oversold RSI 28..... Early July LABU was $333 and RSI of 74....At $249 ( THE JIM CRAMER INVERSE TRADE) IT IS 34....LABU 3X BIOTECH Early July COYA was $6 RSI 72. Now at $4.40 it is 28 .....You can buy where the institutions purchased... LABU OFF 24% COYA OFF 24% $COYA trades like 3x both ways not XBI.... I am a big buyer in my little world today...I believe tomorrow with the release of Dr Reddy's Q1 Earnings it will provide clarity on the 483 letter they submitted to the FDA. They will give a timeline of ABATACEPT in the US which is important. I believe TODAY will be the NADIR on the price of $COYA. LONGER AND STRONGER....$COYA P.S. TRIAL IS 1 DAY CLOSER TO FULL ENROLLMENT......BINARY BETS ARE COMING...
1 · Reply
Layne_Thomas_Staley
Layne_Thomas_Staley Jul. 21 at 10:08 AM
$XBI Strong pre-market $GANX $COYA
0 · Reply
john_Ennis
john_Ennis Jul. 20 at 9:02 PM
$COYA another down day. Just a few percent bu 14 percent in last 10 days.
0 · Reply
Layne_Thomas_Staley
Layne_Thomas_Staley Jul. 20 at 6:04 PM
0 · Reply
Robby83
Robby83 Jul. 20 at 6:00 PM
$COYA still liking this zone... Added a bit more.
1 · Reply
zampy
zampy Jul. 20 at 4:18 PM
$COYA Bot more at absurd prices need a student loan..$4 45 area
0 · Reply
zampy
zampy Jul. 19 at 11:32 AM
$COYA 1. Semaglutide has ZERO to do with $COYA 2. The Bachupally 483 ( Dr Reddy's) is a PAPERWORK issue. 3. The science and Allstars trial remain full steam ahead....Enrollment will be complete in my opinion ahead of schedule in Sept 23rd my guess. 4. Dr Reddy's earnings report comes July 22nd in am....They will give guidance on their Bachupally issue and upfate the street on their expectation of abatacept in US for R.A. I believe this will act as a catalyst for $COYA when Dr Reddy's gives us clarity on their paperwork issue. Takeaway: Take advantage of the Jim Cramer inverse trade and the confusion over semaglutide ( again nothing to do with $COYA) as well as the PAPERWORK issues at Bachupally. July 22nd will give us a bump on the clarity at Bachupally.
1 · Reply
zampy
zampy Jul. 18 at 5:50 PM
$COYA Poignant point: On July 22nd RDY Q1 2027 call.....Here is what is key: Clinical supply vs Commercial lines Listen to them ( RDY) TO CONFIRM ongoing clinical trial supply for partners ( meaning Coya's 302 trial) is completely insulated from these commercial lines.... The stock is going to lift after this call....I am pretty confident.
0 · Reply
Latest News on COYA
Coya Therapeutics Slides: Investor presentation

Jun 29, 2026, 7:00 AM EDT - 22 days ago

Coya Therapeutics Slides: Investor presentation


Coya Therapeutics Transcript: AGM 2026

Jun 25, 2026, 1:00 PM EDT - 26 days ago

Coya Therapeutics Transcript: AGM 2026


Coya Therapeutics Transcript: Investor update

Jun 24, 2026, 4:00 PM EDT - 26 days ago

Coya Therapeutics Transcript: Investor update


Coya Therapeutics initiated with a Buy at Roth Capital

2026-06-05T08:20:06.000Z - 6 weeks ago

Coya Therapeutics initiated with a Buy at Roth Capital


Coya Therapeutics Slides: Investor presentation

Jun 1, 2026, 7:00 AM EDT - 7 weeks ago

Coya Therapeutics Slides: Investor presentation


Coya Therapeutics Proxy statement: Proxy filing

May 13, 2026, 8:00 AM EDT - 2 months ago

Coya Therapeutics Proxy statement: Proxy filing


Coya Therapeutics Proxy statement: Proxy filing

May 13, 2026, 8:00 AM EDT - 2 months ago

Coya Therapeutics Proxy statement: Proxy filing


Coya Therapeutics reports Q1 EPS (32c), consensus (39c)

2026-05-12T11:49:47.000Z - 2 months ago

Coya Therapeutics reports Q1 EPS (32c), consensus (39c)


Coya Therapeutics Earnings release: Q1 2026

May 12, 2026, 7:30 AM EDT - 2 months ago

Coya Therapeutics Earnings release: Q1 2026


Coya Therapeutics Quarterly report: Q1 2026

May 12, 2026, 7:30 AM EDT - 2 months ago

Coya Therapeutics Quarterly report: Q1 2026


Coya Therapeutics Slides: Investor presentation

May 11, 2026, 2:00 AM EDT - 2 months ago

Coya Therapeutics Slides: Investor presentation


Coya Therapeutics Slides: Corporate presentation

May 1, 2026, 7:00 AM EDT - 2 months ago

Coya Therapeutics Slides: Corporate presentation


Coya Therapeutics announces publication of research on COYA 302

2026-04-09T12:26:37.000Z - 3 months ago

Coya Therapeutics announces publication of research on COYA 302


Coya Therapeutics Executive Chairman Howard Berman steps down

2026-04-02T12:17:50.000Z - 3 months ago

Coya Therapeutics Executive Chairman Howard Berman steps down


Coya Therapeutics Slides: Investor presentation

Apr 2, 2026, 7:00 AM EDT - 3 months ago

Coya Therapeutics Slides: Investor presentation


Coya Therapeutics Annual report: Q4 2025

Mar 16, 2026, 8:00 AM EDT - 4 months ago

Coya Therapeutics Annual report: Q4 2025


Coya Therapeutics Earnings release: Q4 2025

Mar 16, 2026, 8:00 AM EDT - 4 months ago

Coya Therapeutics Earnings release: Q4 2025


Coya Therapeutics Registration statement: Registration Filing

Mar 16, 2026, 8:00 AM EDT - 4 months ago

Coya Therapeutics Registration statement: Registration Filing


Coya Therapeutics Transcript: Status update

Feb 17, 2026, 3:00 PM EST - 5 months ago

Coya Therapeutics Transcript: Status update


Coya Therapeutics Slides: Status update

Feb 17, 2026, 3:00 PM EST - 5 months ago

Coya Therapeutics Slides: Status update


Coya Therapeutics Announces $11.1 Million Private Placement

Jan 30, 2026, 8:00 AM EST - 6 months ago

Coya Therapeutics Announces $11.1 Million Private Placement


Coya Therapeutics commences dosing in ALSTARS trial

2025-12-09T13:11:58.000Z - 8 months ago

Coya Therapeutics commences dosing in ALSTARS trial


Coya Therapeutics Slides: Investor Presentation

Nov 30, 2025, 6:00 PM EST - 8 months ago

Coya Therapeutics Slides: Investor Presentation


Coya Therapeutics reports Q3 EPS (13c), consensus (30c)

2025-11-12T13:20:43.000Z - 8 months ago

Coya Therapeutics reports Q3 EPS (13c), consensus (30c)


Coya Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 8 months ago

Coya Therapeutics Quarterly report: Q3 2025


Coya Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 8 months ago

Coya Therapeutics Earnings release: Q3 2025


Coya Therapeutics 3.64M Spot Secondary priced at $5.50

2025-10-24T10:35:20.000Z - 9 months ago

Coya Therapeutics 3.64M Spot Secondary priced at $5.50


Coya Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Earnings release: Q2 2025


Coya Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Quarterly report: Q2 2025


Coya Therapeutics Registration statement: Registration Filing

Aug 12, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Registration statement: Registration Filing


Coya Therapeutics Proxy statement: Proxy Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Proxy statement: Proxy Filing


Coya Therapeutics Proxy statement: Proxy Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Proxy statement: Proxy Filing


Coya Therapeutics Quarterly report: Q1 2025

May 13, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Quarterly report: Q1 2025


Coya Therapeutics Earnings release: Q1 2025

May 13, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Earnings release: Q1 2025


Coya Therapeutics Annual report: Q4 2024

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Annual report: Q4 2024


Coya Therapeutics Earnings release: Q4 2024

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Coya Therapeutics Earnings release: Q4 2024


Layne_Thomas_Staley
Layne_Thomas_Staley Jul. 21 at 3:40 PM
$IBB $XBI $GANX $COYA Yes X1000
0 · Reply
Layne_Thomas_Staley
Layne_Thomas_Staley Jul. 21 at 3:33 PM
$XBI $GANX $COYA XBI is key until news. A rising XBI will provide an impetus for larger players to assume greater risk and accumulate at current prices.
0 · Reply
zampy
zampy Jul. 21 at 10:52 AM
$COYA at $6 RSI was 72 now at $4.X. 40 ( this is the price Dr Reddy's paid as well as David Eihorn whete we raised 22m clean no warrants) we are at a very oversold RSI 28..... Early July LABU was $333 and RSI of 74....At $249 ( THE JIM CRAMER INVERSE TRADE) IT IS 34....LABU 3X BIOTECH Early July COYA was $6 RSI 72. Now at $4.40 it is 28 .....You can buy where the institutions purchased... LABU OFF 24% COYA OFF 24% $COYA trades like 3x both ways not XBI.... I am a big buyer in my little world today...I believe tomorrow with the release of Dr Reddy's Q1 Earnings it will provide clarity on the 483 letter they submitted to the FDA. They will give a timeline of ABATACEPT in the US which is important. I believe TODAY will be the NADIR on the price of $COYA. LONGER AND STRONGER....$COYA P.S. TRIAL IS 1 DAY CLOSER TO FULL ENROLLMENT......BINARY BETS ARE COMING...
1 · Reply
Layne_Thomas_Staley
Layne_Thomas_Staley Jul. 21 at 10:08 AM
$XBI Strong pre-market $GANX $COYA
0 · Reply
john_Ennis
john_Ennis Jul. 20 at 9:02 PM
$COYA another down day. Just a few percent bu 14 percent in last 10 days.
0 · Reply
Layne_Thomas_Staley
Layne_Thomas_Staley Jul. 20 at 6:04 PM
0 · Reply
Robby83
Robby83 Jul. 20 at 6:00 PM
$COYA still liking this zone... Added a bit more.
1 · Reply
zampy
zampy Jul. 20 at 4:18 PM
$COYA Bot more at absurd prices need a student loan..$4 45 area
0 · Reply
zampy
zampy Jul. 19 at 11:32 AM
$COYA 1. Semaglutide has ZERO to do with $COYA 2. The Bachupally 483 ( Dr Reddy's) is a PAPERWORK issue. 3. The science and Allstars trial remain full steam ahead....Enrollment will be complete in my opinion ahead of schedule in Sept 23rd my guess. 4. Dr Reddy's earnings report comes July 22nd in am....They will give guidance on their Bachupally issue and upfate the street on their expectation of abatacept in US for R.A. I believe this will act as a catalyst for $COYA when Dr Reddy's gives us clarity on their paperwork issue. Takeaway: Take advantage of the Jim Cramer inverse trade and the confusion over semaglutide ( again nothing to do with $COYA) as well as the PAPERWORK issues at Bachupally. July 22nd will give us a bump on the clarity at Bachupally.
1 · Reply
zampy
zampy Jul. 18 at 5:50 PM
$COYA Poignant point: On July 22nd RDY Q1 2027 call.....Here is what is key: Clinical supply vs Commercial lines Listen to them ( RDY) TO CONFIRM ongoing clinical trial supply for partners ( meaning Coya's 302 trial) is completely insulated from these commercial lines.... The stock is going to lift after this call....I am pretty confident.
0 · Reply
zampy
zampy Jul. 18 at 4:29 PM
$COYA Dr Reddy's RDY has their Q1 2027 This week Wed July 22nd. They will tell the street what their expectations are for antacept to roll out later 2026.... The Pre Bli was scheduled in zinfua it is about the clearing of the papeerwork and documentation NOT ABOUT COYA 302/ science. Trials ongoing. Takeaway: the market will feel relieved when Dr Reddy's provides color on the 483 and gives insight on their path to US commercialization for abatacept for R.A.
0 · Reply
zampy
zampy Jul. 18 at 4:11 PM
$COYA Downside 50 cents upside dollars......
0 · Reply
zampy
zampy Jul. 17 at 10:43 PM
$COYA Bottom line with 45m in cash and enrollent coming to completion on September 23rd in my humbled opinion....Guys will put on a big binary bet...it is right around the the corner... Catalysts 1. very oversold and misunderstood semaglutide and the 483 RSI JIKE 31 NOW!!! 2. ENROLLMENT OF 120 PATIENTS COMING..MY THOUGHTS SEPT 23RD 120 PATIENTS 3. FTD 60 PATIENTS COMING 2A 4. PROTEOMICS...HUGE LIKE THE PEER REVIEW..THOUSANDS OF PROTEINS VERY SIGNIFICANT...NEEDLE MOVING. 5. BUYOUT RDY???? CANT AFFORD US AT $50...BMS REAQUIRE THEIR MOLECULE.. OPPORTUNITY OF A LIFETIME.....NO DOUBT IN MY MIND
0 · Reply
zampy
zampy Jul. 17 at 10:21 PM
$COYA To be clear today is July 17th and our ALLSTARS TRIAL continues...As the facility in INDIA is brand new and the issues are more alligned with procedurial events and documentation.. MOST IMPORTANT: WE ARE NOT SET FOR COMMERCIALIZATION UNTIL 2028...SO USE THIS AN AN OPPORTUNITY TO STEAL SHARES... THERE IS ABOUT 1M SHARES SHORT..THESE PEOPLE WILL GET RUN OVER AS ODDS ARE IN OUR FAVIR ON MANY FRONTS... 3 buddies and myself bot 159k today....ok
0 · Reply
zampy
zampy Jul. 17 at 10:16 PM
$COYA So the reality is some investors are concerned about Dr Reddy's 483 they received on June 25th. The reality is the stick was $5.13 on that day which was Thursday... The following day we were up to $5.50.... So you had all weekend to digest the RDY news...The ALLSTARS TRIAL HAS NOT STOPPED...So on Monday the 29th of June we hit $6.10....Again all weekend long to think about the RDY NEWS....nada... In fact we averaged the next 9 yrading days $5.76....Clearly people knew the news. In July 9th RDY received semaglutide news their version of the GLP shot...Had issues..Fir whatever reason on that day we went from $5.50 to $5.23...People were associating that with us as Lately ive been asked many questiins regarding that has ZERO to do with us. It is a potential loss of 200m in revs to RDY...in fact it is more likely that they are DESPERATE to make a move on us... I made a huge mistake years ago on PRVB selling 2 weeks at $9 Before Sanofi bought PRVB at $25..similiar set up..
0 · Reply
BG_BULL
BG_BULL Jul. 17 at 6:37 PM
$COYA Maybe we see ATM in action 🤔
1 · Reply
Robby83
Robby83 Jul. 17 at 5:40 PM
$COYA can only wonder how SP would've played out without an overall market pull back... Loading up!
1 · Reply
zampy
zampy Jul. 17 at 12:28 PM
$COYA At $6.07 the RSI on June 28th Was 72...... At $4.60 the RSI IS 35...another 10 to 15 cents we are grissly oversold at 30.... I am buying today
0 · Reply
zampy
zampy Jul. 17 at 12:17 PM
$COYA From June 25th ( DR REDDY'S RECEIVING 483) to July 7th VWAP $5.77 TOTAL VOLUME 1.7M 1M UP 700K DOWN BALANCE OF POWER 1.35 TO 1.00 June 25th news 483 yet 9 days later yraded from $5.13 as high as $6.07 June 29th... Conclusion mkt LABU 3X AND COYA traded in direct tandem....
0 · Reply
zampy
zampy Jul. 17 at 12:08 PM
$COYA LETS PLAY FULL ENROLLMENT..I believe we reach FULL ENROLLMENT 120 PANTIENTS SEPT 23RD... GUESSES????
0 · Reply
gerryh57
gerryh57 Jul. 17 at 11:55 AM
$COYA the trial will finish on schedule. The batch being used within the trial is a non-issue. The issue is facility compliance in India to produce within GMP guidelines and because this appears to be systemic with repeat occurrences. Coya will finish on time.
1 · Reply
zampy
zampy Jul. 17 at 10:23 AM
$COYA To be clear: When the 483 on June w5th was issued $COYA was $5.13 on a Thursday...It traded fo $6.07 on June 29th. And from July 1st to July 7th vwap $5.78. It is a paperwork/ documentation issue not contamination as if it was the Allstars trial would have been interippted not a safety issue. The trial moving full speed ahead. So when RDY gets this cleared up at the new facility this will be another caralyst to get us going. I am waiting for Leerink ti issue a buy day 60 since ATM NEWS. i tepeat no way are they here for 3% on 30m 900k...peanuts. I am pretty sure they will put an outperform on us typically they wait 50 days when they get involved with an ATM. FTD should srart imo next 90 days or less. Proteomics In Oct/Nov data akin to April 9th longitudinal but thousands of proteins for ALS/ ALZHEIMERS. Load zone....taking out a student loan...
0 · Reply